NR 565 Advanced Pharmacology Final Exam 2026/2027 | 90+ Questions & Correct Answers | Cardiovascular, Diabetes, Respiratory, Endocrine, GI & Antimicrobials

This NR 565 Advanced Pharmacology Final Exam Review 2026/2027 is a 16-page exam-preparation resource containing 90+ questions with correct answers covering high-yield pharmacology concepts relevant to advanced nursing practice. The review emphasizes drug selection, mechanisms of action, adverse effects, contraindications, drug interactions, laboratory monitoring and patient education across cardiovascular, endocrine, metabolic, respiratory, infectious-disease and gastrointestinal pharmacotherapy. The source clearly identifies the course as NR 565 Advanced Pharmacology, but it does not name a university, so no unsupported institution has been added. A major portion of the review concentrates on cardiovascular pharmacology and hypertension management. Students encounter nitrates and nitrate-free periods, thiazide and loop diuretics, spironolactone, beta-adrenergic blockers, ACE inhibitors, alpha-adrenergic blockers and calcium-channel blockers. Specific medications include nitroglycerin, atenolol, metoprolol, propranolol, enalapril, methyldopa, prazosin, doxazosin and amlodipine. Questions examine preload and afterload reduction, cardiac contractility, blood-pressure management, pregnancy considerations, heart failure and medication-related effects such as peripheral edema, cough and bradycardia. The resource also provides extensive preparation on heart failure, dysrhythmias and anticoagulation. It reviews cardiac glycosides and digoxin, anti-dysrhythmic medications, procainamide, heparin, warfarin and vitamin K-dependent clotting factors. Students are tested on heparin's relationship with antithrombin III, age-related anticoagulant responses, warfarin interactions and the use of the International Normalized Ratio (INR) for outpatient warfarin monitoring. The material additionally connects morphine, nitroglycerin and vasodilator therapy with changes in preload and afterload during heart failure management. Another high-yield section covers lipid-lowering pharmacotherapy and cardiovascular risk reduction. Questions address HMG-CoA reductase inhibitors, lovastatin, gemfibrozil, bile-acid sequestrants and ezetimibe, together with LDL targets, hypertriglyceridemia and adverse effects. Statin-related content includes myopathy, generalized muscle pain, rhabdomyolysis, potential drug interactions and liver-function monitoring. The document itself includes a note discussing FDA information concerning periodic liver-function testing and statin warnings. The endocrine and diabetes pharmacology portion reviews thyroid-stimulating hormone, hyperthyroidism, Graves' disease, antithyroid therapy and levothyroxine dosing considerations in older adults. Diabetes questions address metformin, sulfonylureas, meglitinides, corticosteroid-induced hyperglycemia and beta-blocker-associated concerns in insulin-dependent patients. The review emphasizes medication selection based on glucose patterns, hypoglycemia risk, age and comorbidities and includes adverse-effect monitoring such as lactic acidosis with metformin. Students also receive review of pharmacokinetics and age-related medication considerations. The document covers the role of hepatic cytochrome P450, plasma-protein binding, albumin availability, drug distribution, medication half-life and the prolonged action of fat-soluble drugs in older adults. These questions connect foundational pharmacokinetic principles with prescribing and monitoring decisions in elderly patients. The respiratory section addresses asthma, COPD, bronchitis, emphysema, pneumonia and influenza pharmacotherapy. Medications and classes represented include albuterol, fluticasone, salmeterol, ipratropium, theophylline, antihistamines, corticosteroids, leukotriene inhibitors, azithromycin, levofloxacin and oseltamivir. Questions distinguish maintenance from rescue therapy, examine pharmacological approaches to mild and moderate persistent asthma, address exercise-induced asthma and reinforce that long-acting bronchodilators such as salmeterol are not intended to provide immediate relief during an acute asthma attack. The document further reviews antimicrobial and anti-infective pharmacology, including treatment scenarios involving community-acquired pneumonia, recurrent herpes simplex virus type 2, bacterial conjunctivitis and dental procedures in patients with a history of rheumatic fever and valvular disease. Drugs represented include azithromycin, levofloxacin, acyclovir, amoxicillin and bacitracin/polymyxin ophthalmic therapy. The final portion focuses on gastrointestinal pharmacology. Students review gastric parietal cells and hydrochloric acid, NSAID-related gastric mucosal injury, antacids, H2-receptor antagonists, sucralfate, misoprostol, antidiarrheals and laxatives. Specific medications include calcium carbonate, cimetidine, diphenoxylate, loperamide, methylcellulose, prochlorperazine, sucralfate and misoprostol. The material also addresses H. pylori-associated recurrent gastric ulcers, constipation in older adults, magnesium-containing antacids, GERD and medication-related exacerbation of reflux symptoms. Overall, this review is particularly valuable for students who need to connect drug classes and individual medications with clinical prescribing decisions rather than simply memorizing drug names. Questions repeatedly test which medication is appropriate for a specific clinical presentation, which adverse effect requires monitoring, what interaction or contraindication should be recognized and what patient education is necessary. Because some statements in the uploaded study material may reflect the source's specific course framing or older pharmacotherapy recommendations, students should use their current NR 565 course materials and prescribing guidelines when verifying clinical practice recommendations. Relevant students: This document is particularly relevant for NR 565 students, Advanced Pharmacology students, Family Nurse Practitioner (FNP) students, Adult-Gerontology Nurse Practitioner students, MSN students, DNP students, APRN students, advanced practice nursing students, nurse practitioner pharmacology students and graduate nursing students preparing for advanced pharmacology final examinations. Academic Reference Katzung, B. G., & Vanderah, T. W. Basic & Clinical Pharmacology. McGraw Hill. This is a relevant supporting pharmacology reference for the document's major subject areas, including pharmacokinetics, autonomic and cardiovascular drugs, anticoagulants, endocrine pharmacology, respiratory medications, antimicrobial therapy and gastrointestinal drugs. The uploaded document does not identify a specific required textbook or edition, so this reference should not be interpreted as the confirmed source of its questions. Keywords NR 565 Advanced Pharmacology, NR 565 final exam, NR 565 final exam 2026, NR 565 final exam 2027, NR 565 questions and answers, NR 565 exam review, NR 565 study guide, Advanced Pharmacology final exam, Advanced Pharmacology questions and answers, nurse practitioner pharmacology, FNP pharmacology exam, APRN pharmacology, MSN pharmacology, DNP pharmacology, pharmacokinetics, cytochrome P450, drug half life, cardiovascular pharmacology, hypertension medications, antihypertensive drugs, ACE inhibitors, beta blockers, calcium channel blockers, thiazide diuretics, loop diuretics, spironolactone, nitroglycerin therapy, heart failure pharmacology, digoxin, cardiac glycosides, anticoagulant pharmacology, heparin, warfarin, INR monitoring, lipid lowering medications, statins, lovastatin, rhabdomyolysis, diabetes pharmacology, metformin, sulfonylureas, meglitinides, thyroid pharmacology, levothyroxine, Graves disease medications, respiratory pharmacology, asthma medications, COPD medications, albuterol, salmeterol, fluticasone, ipratropium, theophylline, antimicrobial pharmacology, azithromycin, levofloxacin, acyclovir, amoxicillin, gastrointestinal pharmacology, GERD medications, antacids, H2 blockers, cimetidine, sucralfate, misoprostol, H pylori treatment, advanced pharmacology exam preparation